Nasdaq
$0.2340▲ 0.43%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $4.0MShares out 17.2M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
19- 10.9After-hours26.10.10 05:018-KKey event#●●●#●●●
MANGOCEUTICALS, INC.
Mangoceuticals, Inc. (MGRX) closed a registered direct offering on October 8, 2026, raising approximately $492,750 in gross proceeds. The offering consisted of 657,000 shares of common stock and accompanying warrants at a combined price of $0.75 per unit, with proceeds intended for working capital and general corporate purposes.…more
$0.2340+0.43%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.9After-hours26.10.10 05:00424B5Offering
MANGOCEUTICALS, INC.
Mangoceuticals, Inc. (MGRX) is conducting a public offering of 657,000 shares of common stock and accompanying warrants to purchase up to 657,000 shares at a combined price of $0.75 per unit. The company expects to raise approximately $475,000 in net proceeds to be used for working capital and general corporate purposes. The warrants are immediately exercisable at $1.00 per share and will expire five years from the date of issuance.…more
$0.2340+0.43%vs prev closeView filingShare - 10.6Pre-market26.10.06 21:004Ownership
MANGOCEUTICALS, INC.
Mangoceuticals, Inc. (MGRX) has filed a Form 4 reporting changes in beneficial ownership by insider Jacob D. Cohen and Tiger Cub Trust. The filing details the status of their holdings as of September 30, 2025.…more
$0.2340+0.43%vs prev closeView filingShare
18 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.9After-hours26.10.10 05:01Bullish#●●●#●●●#●●●
Mangoceuticals Closes Registered Direct Offering
Mangoceuticals has completed a registered direct offering of approximately $500,000 at a premium to its recent market price. Investors should note that this transaction involves the issuance of common stock and warrants, which may lead to potential dilution.…more
$0.2340+0.43%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 10.2Overnight26.10.02 14:22
●●●●●●●● ●●●●● ●●●●●●
Mangoceuticals shares fell 12% after hours despite announcing a $2.5 million strategic investment into its former subsidiary, MangoRx IP Holdings. While the deal involves no dilution of Mangoceuticals common stock, the market reacted negatively to the news.…more
$0.2340+0.43%vs prev closeShareBenzinga - 10.1Regular26.10.02 04:50
●●●●●●●● ●●●●● ●●●●●●
Mangoceuticals has secured a $2.5 million strategic investment into its subsidiary, MangoRx IP Holdings, with no issuance of parent company stock. This subsidiary-level transaction provides capital for intellectual property commercialization without diluting existing shareholders.…more
$0.2340+0.43%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report